Scientific Reports (Dec 2023)

Detection and persistence of Zika virus in body fluids and associated factors: a prospective cohort study

  • Guilherme Amaral Calvet,
  • Edna Oliveira Kara,
  • Camila Helena Aguiar Bôtto-Menezes,
  • Marcia da Costa Castilho,
  • Rafael Freitas de Oliveira Franca,
  • Ndema Habib,
  • Armando Menezes Neto,
  • Gerson Fernando Mendes Pereira,
  • Silvana Pereira Giozza,
  • Ximena Pamela Díaz Bermúdez,
  • Tatiana Jorge Fernandes,
  • Kayvon Modjarrad,
  • Patrícia Brasil,
  • Nathalie Jeanne Nicole Broutet,
  • Ana Maria Bispo de Filippis,
  • ZIKABRA Study Team

DOI
https://doi.org/10.1038/s41598-023-48493-8
Journal volume & issue
Vol. 13, no. 1
pp. 1 – 18

Abstract

Read online

Abstract This study aimed to analyze the detection and duration of the Zika virus (ZIKV) in plasma, urine, saliva, sweat, rectal swabs, vaginal secretions, breast milk, and semen and to explore risk factors associated with prolonged viral persistence. A prospective cohort study of symptomatic patients and their household contacts was conducted in Brazil from July 2017 to June 2019. A total of 260 individuals (184 women and 76 men) with confirmed ZIKV infection were enrolled and followed up for 12 months. ZIKV RNA was present in all body fluid specimens and detectable for extended periods in urine, sweat, rectal swabs, and semen. The longest detection duration was found in semen, with high viral loads in the specimens. ZIKV RNA clearance was associated with several factors, including age, sex, education level, body mass index, non-purulent conjunctivitis, joint pain, and whether the participant had a history of yellow fever vaccination. The influence of each of these factors on the low or fast viral clearance varied according to the specific body fluid under investigation. Recurrent ZIKV detection events after total viral clearance were observed in the cohort. Our findings provide valuable insights into the persistence and potential recurrence of ZIKV infection, highlighting the need for continued monitoring and follow-up of individuals infected with ZIKV and for effective prevention measures to reduce the risk of transmission.